+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Kidneys Models Market by Model Type (Cell-Based Assays, Computational Models, Organ-on-Chip), Product Type (2D Models, 3D Models), Application, End User - Global Forecast 2025-2030- Product Image
Human Kidneys Models Market by Model Type (Cell-Based Assays, Computational Models, Organ-on-Chip), Product Type (2D Models, 3D Models), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Human Kidneys Models Market by Model Type (Cell-Based Assays, Computational Models, Organ-on-Chip), Product Type (2D Models, 3D Models), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6128731
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Human kidney models have undergone a remarkable evolution over the past decade, catalyzed by urgent demands for more predictive preclinical platforms and greater physiological relevance. As chronic kidney disease remains a persistent global health challenge, researchers have pursued refined in vitro and in silico approaches that not only replicate key aspects of nephron architecture but also integrate complex molecular signaling pathways. The convergence of cellular biology, engineering, and computational sciences has elevated our capacity to simulate filtration, reabsorption, and secretion processes with unprecedented fidelity.

Transitioning from traditional cell line assays to advanced three-dimensional constructs and microfluidic systems, the field has embraced solutions that reduce reliance on animal studies and offer higher throughput insights. Meanwhile, artificial intelligence-driven modeling has enhanced our ability to anticipate compound toxicity and metabolic interactions before costly in vivo trials. This introduction sets the stage for a deep exploration of shifting paradigms, regulatory influences, segmentation dynamics, regional variances, and strategic imperatives, providing leaders with an informed foundation to accelerate therapeutic discovery and patient-centric innovation.

Emerging Innovations and Converging Disciplines Are Reshaping the Landscape of Human Renal Models Toward Greater Accuracy and Predictive Power

Over recent years, the landscape of human kidney models has been reshaped by cross-disciplinary breakthroughs that blur the lines between biology and engineering. Microfabrication techniques now produce organ-on-chip devices capable of recreating fluidic shear forces and endothelial interfaces, while bioprinting methods enable the assembly of tubular structures with spatial precision. These transformative innovations have been complemented by advances in computational modeling, where machine learning algorithms sift through vast datasets to predict nephrotoxicity and optimize dosing regimens.

In parallel, improvements in stem cell biology have yielded organoids that recapitulate nephron subtypes and patient-specific genetic profiles, fueling personalized medicine initiatives. Regulatory bodies have begun to recognize these models as potential replacements for certain animal tests, signaling a shift toward more ethically responsible research practices. Consequently, stakeholders are investing in hybrid platforms that marry three-dimensional constructs with fluidic controls and real-time imaging, marking a new era of dynamic, predictive, and human-relevant kidney models.

Evaluating the Broad Ramifications of New United States Tariff Measures on Material Costs Supply Chains and Research Collaborations in 2025

The imposition of updated tariff schedules by the United States in 2025 has had a ripple effect across supply chains, procurement budgets, and collaborative research initiatives. Suppliers of specialized reagents and microelectronic components used in kidney-on-chip devices have encountered increased costs, prompting many manufacturers to reevaluate their sourcing strategies. As a result, research institutions have sought alternative vendors in regions offering lower import duties, while some have repurposed existing materials to maintain budgetary alignment.

Moreover, heightened import tariffs have stimulated dialogue between policymakers and industry stakeholders regarding the importance of safeguarding scientific innovation. Collaborative research partnerships with overseas academic centers have been renegotiated to offset cost burdens, and some consortia have pursued joint grant submissions to secure funding for tariff-related expenses. In essence, these cumulative impacts underscore the delicate balance between ensuring national trade policies and nurturing a thriving research ecosystem poised to deliver next-generation therapeutic insights.

Deep Dive into Segmentation Frameworks Reveals How Model Types Product Configurations Applications and End Users Define Industry Dynamics

Market segmentation insights reveal diverse approaches shaping the development and application of kidney models. Based on Model Type, research efforts span cell-based assays, computational models, and organ-on-chip platforms. The cell-based category encompasses immortalized cell lines prized for reproducibility, primary cell cultures that maintain donor-specific phenotypes, and stem cell-derived cells capable of reflecting developmental processes. Computational approaches leverage AI-driven modeling to interpret large biological datasets and in silico simulations to predict pharmacokinetics. Organ-on-chip systems include kidney-on-chip devices that mimic nephron microenvironments, as well as multi-organ platforms that integrate renal function with cardiovascular and hepatic models.

From the standpoint of product type, two-dimensional constructs include co-culture models fostering cell-cell interactions, and monolayer cultures optimized for high-throughput screening. Three-dimensional models extend this foundation through organoids offering self-organized complexity, scaffolds providing structural support, and spheroids enabling gradient formation. Application-based segmentation covers disease modeling to unravel pathophysiology, drug discovery and development for efficacy and safety assessment, personalized medicine that tailors therapies to individual genetic profiles, and toxicity testing to safeguard patient health. Finally, end-user analysis identifies academic and research institutes at the forefront of foundational science, contract research organizations delivering turnkey solutions, hospitals and clinics integrating models into translational workflows, and pharmaceutical and biotechnology companies driving therapeutic pipelines.

Comparative Examination of Regional Market Characteristics Highlights Unique Drivers Constraints and Collaboration Opportunities across Key Geographies

Regional dynamics in the human kidney model space exhibit distinct patterns of investment, regulation, and collaboration. In the Americas, robust funding streams and well-established biotechnological infrastructures have fostered rapid adoption of organ-on-chip and advanced bioprinting platforms, while government-led initiatives promote public-private partnerships to combat kidney disease. Transitioning eastward, Europe, Middle East & Africa display varied regulatory frameworks that influence model validation and data acceptance; here, pan-European consortia work diligently to harmonize standards, and select Middle Eastern nations have launched incubators to attract cutting-edge research.

Meanwhile, the Asia-Pacific region stands out for its combination of cost-competitive manufacturing capabilities and burgeoning research ecosystems. Countries within this geography are expanding stem cell programs, investing in AI laboratories, and forging global alliances to access critical microfluidic technologies. These regional insights highlight how local policy landscapes, economic incentives, and scientific networks collectively shape the trajectory of human kidney model innovation across the globe.

Leading Organizations Are Championing Cutting Edge Human Kidney Model Advancements through Strategic Partnerships Technology Investments and Scientific Excellence

A cadre of organizations has emerged as leaders in the development and commercialization of human kidney models, distinguished by their strategic partnerships, robust innovation pipelines, and investment in scientific excellence. These entities have prioritized collaborations with academic centers to accelerate platform validation and have joined forces with biopharma companies to tailor model characteristics around specific therapeutic targets. Many have established in-house engineering teams to advance microfabrication capabilities, while others have integrated proprietary software to enhance computational modeling fidelity.

In addition, forward-thinking firms have invested in quality management systems and regulatory affairs expertise to expedite model acceptance by oversight agencies. By balancing foundational research with scalable manufacturing processes, these companies are not only setting technical benchmarks but also defining best practices for supply chain resilience, data interoperability, and cross-industry knowledge sharing.

Strategic Imperatives for Industry Leaders Emphasize Collaboration Technology Adoption Diversified Sourcing and Regulatory Alignment to Enhance Competitive Position

Industry leaders can capitalize on emerging opportunities by forging collaborative consortia that unify expertise in biology, engineering, and data analytics. Such alliances will accelerate the co-development of hybrid platforms that combine organoid complexity with real-time monitoring capabilities. It is imperative to diversify sourcing strategies by qualifying multiple supply partners, thereby mitigating risks associated with trade policy shifts and component shortages.

Furthermore, aligning internal workflows with evolving regulatory frameworks will facilitate smoother validation pathways and broader market acceptance. Organizations should also invest in talent acquisition for multidisciplinary roles that bridge computational modeling, microfluidics, and stem cell biology. By embedding continuous learning programs and advancing open-science initiatives, companies will not only future-proof their pipelines but also enhance collaborative transparency across the broader research community.

Robust Mixed Methodology Combining Primary Expert Interviews Secondary Publication Reviews and Rigorous Validation Ensures Comprehensive Research Integrity

This research integrates primary and secondary approaches to ensure a rigorous and balanced analysis of the human kidney model landscape. Primary interviews were conducted with leading academic researchers, technology developers, and regulatory specialists, yielding firsthand insights into emerging challenges and best practices. Secondary data were sourced from peer-reviewed journals, industry white papers, and reputable conference proceedings, providing foundational context and historical trends.

Quantitative validation was achieved through cross-referencing experimental performance metrics and supply chain data, while qualitative findings underwent peer review by an advisory panel of subject-matter experts. The methodology emphasizes transparency and replicability, with detailed documentation of data collection protocols and analytic frameworks to uphold the highest standards of research integrity.

Synthesis of Critical Findings Demonstrates the Transformative Potential of Advanced Kidney Model Platforms to Accelerate Research and Therapeutic Innovation

Bringing together technological breakthroughs, regulatory shifts, and strategic imperatives, the analysis underscores a clear pathway toward more predictive, efficient, and ethically responsible kidney models. Advanced microfluidic and three-dimensional platforms are poised to replace traditional assays, supported by AI-driven simulations that streamline candidate selection. Meanwhile, tariff considerations and regional distinctions highlight the necessity of supply chain agility and localized collaboration.

Collectively, these insights chart a forward-looking vision in which personalized medicine and high-throughput screening converge to accelerate therapeutic discovery. By embracing multidisciplinary innovation and proactive regulatory engagement, stakeholders can unlock transformative possibilities in nephrology research, ultimately improving patient outcomes through more precise, human-relevant preclinical evaluation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Model Type
    • Cell-Based Assays
      • Cell Lines
      • Primary Cell Cultures
      • Stem Cell-Derived Cells
    • Computational Models
      • Ai-Driven Modeling
      • In Silico Simulation
    • Organ-on-Chip
      • Kidney-on-Chip
      • Multi-Organ-on-Chip
  • Product Type
    • 2D Models
      • Co-Culture Models
      • Monolayer Cultures
    • 3D Models
      • Organoids
      • Scaffolds
      • Spheroids
  • Application
    • Disease Modeling
    • Drug Discovery & Development
    • Personalized Medicine
    • Toxicity Testing
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Emulate, Inc.
  • MIMETAS B.V.
  • InSphero AG
  • CN Bio Innovations Limited
  • Organovo Holdings, Inc.
  • TissUse GmbH
  • Hurel Corporation
  • Nortis LLC
  • Hesperos, Inc.
  • AxoSim, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of 3D bioprinted human kidney tissues for preclinical drug toxicity assessment
5.2. Integration of microfluidic kidney-on-a-chip platforms in high throughput nephrotoxicity screening
5.3. Emergence of patient derived kidney organoids for personalized nephrology research and testing
5.4. Collaborations between pharmaceutical companies and organoid specialists to accelerate kidney disease modeling
5.5. Regulatory frameworks evolving to incorporate organoid based nephrotoxicity data in drug approval processes
5.6. Application of machine learning and multi omics data to enhance predictive accuracy of in silico kidney models
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Kidneys Models Market, by Model Type
8.1. Introduction
8.2. Cell-Based Assays
8.2.1. Cell Lines
8.2.2. Primary Cell Cultures
8.2.3. Stem Cell-Derived Cells
8.3. Computational Models
8.3.1. Ai-Driven Modeling
8.3.2. In Silico Simulation
8.4. Organ-on-Chip
8.4.1. Kidney-on-Chip
8.4.2. Multi-Organ-on-Chip
9. Human Kidneys Models Market, by Product Type
9.1. Introduction
9.2. 2D Models
9.2.1. Co-Culture Models
9.2.2. Monolayer Cultures
9.3. 3D Models
9.3.1. Organoids
9.3.2. Scaffolds
9.3.3. Spheroids
10. Human Kidneys Models Market, by Application
10.1. Introduction
10.2. Disease Modeling
10.3. Drug Discovery & Development
10.4. Personalized Medicine
10.5. Toxicity Testing
11. Human Kidneys Models Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals & Clinics
11.5. Pharmaceutical & Biotechnology Companies
12. Americas Human Kidneys Models Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Human Kidneys Models Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Human Kidneys Models Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Emulate, Inc.
15.3.2. MIMETAS B.V.
15.3.3. InSphero AG
15.3.4. CN Bio Innovations Limited
15.3.5. Organovo Holdings, Inc.
15.3.6. TissUse GmbH
15.3.7. Hurel Corporation
15.3.8. Nortis LLC
15.3.9. Hesperos, Inc.
15.3.10. AxoSim, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HUMAN KIDNEYS MODELS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HUMAN KIDNEYS MODELS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HUMAN KIDNEYS MODELS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HUMAN KIDNEYS MODELS MARKET: RESEARCHAI
FIGURE 24. HUMAN KIDNEYS MODELS MARKET: RESEARCHSTATISTICS
FIGURE 25. HUMAN KIDNEYS MODELS MARKET: RESEARCHCONTACTS
FIGURE 26. HUMAN KIDNEYS MODELS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN KIDNEYS MODELS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRIMARY CELL CULTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRIMARY CELL CULTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY AI-DRIVEN MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY AI-DRIVEN MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY IN SILICO SIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY IN SILICO SIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY KIDNEY-ON-CHIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY KIDNEY-ON-CHIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MULTI-ORGAN-ON-CHIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MULTI-ORGAN-ON-CHIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CO-CULTURE MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CO-CULTURE MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MONOLAYER CULTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY MONOLAYER CULTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGANOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGANOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY SPHEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY SPHEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN KIDNEYS MODELS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HUMAN KIDNEYS MODELS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 120. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 121. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 122. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 123. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 124. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 125. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 128. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 129. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 130. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 131. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 138. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 142. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 143. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA HUMAN KIDNEYS MODELS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 230. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 231. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 234. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 235. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 238. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 239. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 240. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 241. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. GERMANY HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 248. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 249. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 250. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 251. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 252. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 253. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 256. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 257. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 258. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 259. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. FRANCE HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 282. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 283. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 284. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 285. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 286. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 287. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 288. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 289. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 292. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 293. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 294. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 295. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. ITALY HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 300. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 301. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 302. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 303. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 304. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 305. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 306. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 307. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 310. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 311. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 312. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 313. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SPAIN HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY COMPUTATIONAL MODELS, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY ORGAN-ON-CHIP, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 2D MODELS, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY 3D MODELS, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES HUMAN KIDNEYS MODELS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Kidneys Models market report include:
  • Emulate, Inc.
  • MIMETAS B.V.
  • InSphero AG
  • CN Bio Innovations Limited
  • Organovo Holdings, Inc.
  • TissUse GmbH
  • Hurel Corporation
  • Nortis LLC
  • Hesperos, Inc.
  • AxoSim, Inc.

Related Reports

Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029 - Product Image

Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029

  • Report
  • 427 Pages
  • Global
From
Anatomy Kidneys Models Market by Model Type (Animal, Human), Material Type (Foam, Gel, Plastic), Product Type, End User, Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Anatomy Kidneys Models Market by Model Type (Animal, Human), Material Type (Foam, Gel, Plastic), Product Type, End User, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Organs-on-Chips - Global Strategic Business Report - Product Image

Organs-on-Chips - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Artificial Organs Market Overview, 2025-30 - Product Image

Artificial Organs Market Overview, 2025-30

  • Report
  • 103 Pages
  • Global
From
Human Lipocalin-2/NGAL ELISA Kit Market by End User, Application Area, Sample Type, Kit Format, Reaction Principle, Distribution Channel - Global Forecast 2025-2030 - Product Image

Human Lipocalin-2/NGAL ELISA Kit Market by End User, Application Area, Sample Type, Kit Format, Reaction Principle, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.